238 related articles for article (PubMed ID: 35751044)
1. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.
Maeda Y; Motooka D; Kawasaki T; Oki H; Noda Y; Adachi Y; Niitsu T; Okamoto S; Tanaka K; Fukushima K; Amiya S; Hara R; Oguro-Igashira E; Matsuki T; Hirata H; Takeda Y; Kida H; Kumanogoh A; Nakamura S; Takeda K
BMC Infect Dis; 2022 Jun; 22(1):572. PubMed ID: 35751044
[TBL] [Abstract][Full Text] [Related]
2. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.
Rizzello F; Viciani E; Gionchetti P; Filippone E; Imbesi V; Melotti L; Dussias NK; Salice M; Santacroce B; Padella A; Velichevskaya A; Marcante A; Castagnetti A
Front Cell Infect Microbiol; 2024; 14():1352202. PubMed ID: 38510960
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
4. Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features.
Lv L; Gu S; Jiang H; Yan R; Chen Y; Chen Y; Luo R; Huang C; Lu H; Zheng B; Zhang H; Xia J; Tang L; Sheng G; Li L
Commun Biol; 2021 Apr; 4(1):480. PubMed ID: 33850296
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
[TBL] [Abstract][Full Text] [Related]
6. Fungal diversity in the gut microbiome of young South African children.
Nel Van Zyl K; Whitelaw AC; Hesseling AC; Seddon JA; Demers AM; Newton-Foot M
BMC Microbiol; 2022 Aug; 22(1):201. PubMed ID: 35978282
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
[TBL] [Abstract][Full Text] [Related]
8. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant.
Wang YZ; Zhou JG; Lu YM; Hu H; Xiao FF; Ge T; Wang X; Zheng L; Yu LH; Le J; Yu H; Yu GJ; Xia Q; Zhang T; Zhou WH
World J Pediatr; 2023 May; 19(5):478-488. PubMed ID: 36627507
[TBL] [Abstract][Full Text] [Related]
10. Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.
Cao D; Liu W; Lyu N; Li B; Song W; Yang Y; Zhu J; Zhang Z; Zhu B
Microbiol Spectr; 2021 Dec; 9(3):e0061521. PubMed ID: 34908436
[TBL] [Abstract][Full Text] [Related]
11. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
[TBL] [Abstract][Full Text] [Related]
13. Early gut mycobiota and mother-offspring transfer.
Schei K; Avershina E; Øien T; Rudi K; Follestad T; Salamati S; Ødegård RA
Microbiome; 2017 Aug; 5(1):107. PubMed ID: 28837002
[TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C).
Suskun C; Kilic O; Yilmaz Ciftdogan D; Guven S; Karbuz A; Ozkaya Parlakay A; Kara Y; Kacmaz E; Sahin A; Boga A; Kizmaz Isancli D; Gulhan B; Kanik-Yuksek S; Kiral E; Bozan G; Arslanoglu MO; Kizil MC; Dinleyici M; Us T; Varis A; Kaya M; Vandenplas Y; Dinleyici EC
Eur J Pediatr; 2022 Aug; 181(8):3175-3191. PubMed ID: 35585256
[TBL] [Abstract][Full Text] [Related]
15. Host Factors Associated with Gut Mycobiome Structure.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method.
Petakh P; Kobyliak N; Kamyshnyi A
Front Cell Infect Microbiol; 2023; 13():1142578. PubMed ID: 36844398
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients.
Sciavilla P; Strati F; Di Paola M; Modesto M; Vitali F; Cavalieri D; Prati GM; Di Vito M; Aragona G; De Filippo C; Mattarelli P
Appl Microbiol Biotechnol; 2021 Apr; 105(8):3277-3288. PubMed ID: 33839797
[TBL] [Abstract][Full Text] [Related]
19. Composition and Associations of the Infant Gut Fungal Microbiota with Environmental Factors and Childhood Allergic Outcomes.
Boutin RCT; Sbihi H; McLaughlin RJ; Hahn AS; Konwar KM; Loo RS; Dai D; Petersen C; Brinkman FSL; Winsor GL; Sears MR; Moraes TJ; Becker AB; Azad MB; Mandhane PJ; Subbarao P; Turvey SE; Finlay BB
mBio; 2021 Jun; 12(3):e0339620. PubMed ID: 34060330
[TBL] [Abstract][Full Text] [Related]
20. A Clinical Study Provides the First Direct Evidence That Interindividual Variations in Fecal β-Lactamase Activity Affect the Gut Mycobiota Dynamics in Response to β-Lactam Antibiotics.
Delavy M; Burdet C; Sertour N; Devente S; Docquier JD; Grall N; Volant S; Ghozlane A; Duval X; Mentré F; d'Enfert C; Bougnoux ME;
mBio; 2022 Dec; 13(6):e0288022. PubMed ID: 36448778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
